# Oregon Biosciences Association
## 2025-26

### [HB 1062](/bill/2025-26/hb/1062/) - Biomarker testing coverage ğŸ‘1  

### [HB 1238](/bill/2025-26/hb/1238/) - Rare diseases adv. council ğŸ‘1  

### [HB 1422](/bill/2025-26/hb/1422/) - Drug take-back program  ğŸ‘1 

### [HB 1444](/bill/2025-26/hb/1444/) - Whole genome sequencing ğŸ‘1  

### [HB 1697](/bill/2025-26/hb/1697/) - Newborn screening additions ğŸ‘1  

### [HB 1725](/bill/2025-26/hb/1725/) - Biosimilar medicines  ğŸ‘1 

### [HB 1971](/bill/2025-26/hb/1971/) - Prescription hormone therapy ğŸ‘2  

### [SB 5064](/bill/2025-26/sb/5064/) - Rare diseases adv. council ğŸ‘1  

### [SB 5326](/bill/2025-26/sb/5326/) - Insulin emergency supply  ğŸ‘1 
* ğŸ‘ğŸ’µ Michael Transue

### [SB 5594](/bill/2025-26/sb/5594/) - Biosimilar medicines  ğŸ‘1 

## [SB 5734](/bill/2025-26/sb/5734/) - Interstate bridge toll bonds ğŸ‘1  

## 2023-24

### [SB 5734](/bill/2023-24/sb/5734/) - Interstate bridge toll bonds ğŸ‘1  

### [HB 1079](/bill/2023-24/hb/1079/) - Whole genome sequencing ğŸ‘1  

### [HB 1269](/bill/2023-24/hb/1269/) - Rx drug affordability board  ğŸ‘1 
* ğŸ‘ğŸ’µ Michael Transue

### [HB 1450](/bill/2023-24/hb/1450/) - Biomarker testing coverage ğŸ‘1  

### [HB 1745](/bill/2023-24/hb/1745/) - Diversity in clinical trials ğŸ‘3  

### [HB 1933](/bill/2023-24/hb/1933/) - Supporting the servicing and right to repair of certain products with digital electronics in a secure and reliable manner.   â“1
* â“ğŸ’µ Michael Transue

### [HB 2482](/bill/2023-24/hb/2482/) - Semiconductor tax incentives ğŸ‘1  

### [SB 5074](/bill/2023-24/sb/5074/) - Biomarker testing coverage ğŸ‘1  

### [SB 5097](/bill/2023-24/sb/5097/) - Rare diseases adv. council ğŸ‘1  

### [SB 5388](/bill/2023-24/sb/5388/) - Diversity in clinical trials ğŸ‘3  

## [SB 5864](/bill/2023-24/sb/5864/) - Rare disease supports ğŸ‘1  
